Literature DB >> 22717872

First trimester serum markers to predict preeclampsia.

Berthold Huppertz1, Rie Kawaguchi.   

Abstract

A variety of different biomarkers to predict preeclampsia have been identified in the last ten years. Most of these markers have been detected and quantified in maternal blood, and their potency to predict preeclampsia prior to the onset of clinical symptoms has been evaluated. The amount of such markers depends on various conditions, including the source of the marker (fetal/placental and/or maternal), the interaction of this marker with other proteins in maternal blood as well as the stability of the markers during freezing and thawing. Here we describe two of the putative early, first trimester biomarkers, placental protein 13 and placental growth factor. There is still the hope that - even in the absence of any treatment regimen today - such predictive markers will help to speed the development of a cure for preeclampsia.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22717872     DOI: 10.1007/s10354-012-0072-5

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  27 in total

1.  Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis.

Authors:  Emmanuel Bujold; Stéphanie Roberge; Yves Lacasse; Marc Bureau; François Audibert; Sylvie Marcoux; Jean-Claude Forest; Yves Giguère
Journal:  Obstet Gynecol       Date:  2010-08       Impact factor: 7.661

2.  First-trimester placental growth factor as a marker for hypertensive disorders and SGA.

Authors:  N J Cowans; A Stamatopoulou; E Matwejew; C S von Kaisenberg; K Spencer
Journal:  Prenat Diagn       Date:  2010-06       Impact factor: 3.050

Review 3.  Latest advances in understanding preeclampsia.

Authors:  Christopher W Redman; Ian L Sargent
Journal:  Science       Date:  2005-06-10       Impact factor: 47.728

Review 4.  Placental origins of preeclampsia: challenging the current hypothesis.

Authors:  Berthold Huppertz
Journal:  Hypertension       Date:  2008-02-07       Impact factor: 10.190

5.  A primate subfamily of galectins expressed at the maternal-fetal interface that promote immune cell death.

Authors:  Nandor Gabor Than; Roberto Romero; Morris Goodman; Amy Weckle; Jun Xing; Zhong Dong; Yi Xu; Federica Tarquini; Andras Szilagyi; Peter Gal; Zhuocheng Hou; Adi L Tarca; Chong Jai Kim; Jung-Sun Kim; Saied Haidarian; Monica Uddin; Hans Bohn; Kurt Benirschke; Joaquin Santolaya-Forgas; Lawrence I Grossman; Offer Erez; Sonia S Hassan; Peter Zavodszky; Zoltan Papp; Derek E Wildman
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-02       Impact factor: 11.205

6.  Increased levels of an apoptotic product in the sera from women with pre-eclampsia.

Authors:  R Rafik Hamad; K Bremme; A Kallner; M Sten-Linder
Journal:  Scand J Clin Lab Invest       Date:  2009       Impact factor: 1.713

7.  A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate.

Authors:  Roberto Romero; Jyh Kae Nien; Jimmy Espinoza; David Todem; Wenjiang Fu; Hwan Chung; Juan Pedro Kusanovic; Francesca Gotsch; Offer Erez; Shali Mazaki-Tovi; Ricardo Gomez; Sam Edwin; Tinnakorn Chaiworapongsa; Richard J Levine; S Ananth Karumanchi
Journal:  J Matern Fetal Neonatal Med       Date:  2008-01

8.  Uterine glands provide histiotrophic nutrition for the human fetus during the first trimester of pregnancy.

Authors:  Graham J Burton; Adrian L Watson; Joanne Hempstock; Jeremy N Skepper; Eric Jauniaux
Journal:  J Clin Endocrinol Metab       Date:  2002-06       Impact factor: 5.958

9.  Maternal plasma concentrations of soluble endoglin in pregnancies with intrauterine growth restriction.

Authors:  Holger Stepan; Thomas Krämer; Renaldo Faber
Journal:  J Clin Endocrinol Metab       Date:  2007-04-10       Impact factor: 5.958

10.  Longitudinal determination of serum placental protein 13 during development of preeclampsia.

Authors:  Berthold Huppertz; Marei Sammar; Ilana Chefetz; Peruka Neumaier-Wagner; Clemens Bartz; Hamutal Meiri
Journal:  Fetal Diagn Ther       Date:  2008-08-28       Impact factor: 2.587

View more
  3 in total

Review 1.  Biomarkers for the management of pre-eclampsia in pregnant women.

Authors:  Lakshmi Tanuja Petla; Rosy Chikkala; K S Ratnakar; Vijayalakshmi Kodati; V Sritharan
Journal:  Indian J Med Res       Date:  2013       Impact factor: 2.375

2.  Biochemical Markers for Prediction of Hypertensive Disorders of Pregnancy.

Authors:  Dušica Kocijančić Belovic; Snežana Plešinac; Jelena Dotlić; Ana Savić Radojević; Slavica Akšam; Mirjana Marjanović Cvjetićanin; Aleksandar Kocijančić
Journal:  J Med Biochem       Date:  2019-03-01       Impact factor: 3.402

3.  Placental Galectins Are Key Players in Regulating the Maternal Adaptive Immune Response.

Authors:  Andrea Balogh; Eszter Toth; Roberto Romero; Katalin Parej; Diana Csala; Nikolett L Szenasi; Istvan Hajdu; Kata Juhasz; Arpad F Kovacs; Hamutal Meiri; Petronella Hupuczi; Adi L Tarca; Sonia S Hassan; Offer Erez; Peter Zavodszky; Janos Matko; Zoltan Papp; Simona W Rossi; Sinuhe Hahn; Eva Pallinger; Nandor Gabor Than
Journal:  Front Immunol       Date:  2019-06-19       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.